2 September 2024
Denmark's Novo Nordisk – which currently supplies 20% of MOH's human insulin supply – says its supply of human insulin to Malaysia has remained stable and it will continue its supply to the country. Novo Nordisk is also in an ongoing dialogue with MOH.